Veterinary Medicines

ALFADEXX 2 MG/ML SOLUTION FOR INJECTION FOR HORSES, CATTLE, GOATS, PIGS, DOGS AND CATS

Authorised
  • DEXAMETHASONE DISODIUM PHOSPHATE
Download as PDF

Product identification

Medicine name:
ALFADEXX 2 MG/ML SOLUTION FOR INJECTION FOR HORSES, CATTLE, GOATS, PIGS, DOGS AND CATS
ALFADEXX 2 MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
  • DEXAMETHASONE DISODIUM PHOSPHATE
Target species:
  • Cattle
  • Pig
  • Cat
  • Horse
  • Goat
  • Dog
Route of administration:
  • Intramuscular use
  • Subcutaneous use
  • Periarticular use
  • Intravenous use
  • Intraarticular use

Product details

Active substance and strength:
  • DEXAMETHASONE DISODIUM PHOSPHATE
    2.63
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Pig
      • Meat and offal
        2
        day
    • Cat
    • Horse
      • Meat and offal
        8
        day
      • Milk
        no withdrawal period
    • Goat
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Dog
  • Subcutaneous use
    • Dog
    • Cat
  • Periarticular use
    • Horse
      • Meat and offal
        8
        day
      • Milk
        no withdrawal period
  • Intravenous use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Pig
      • Meat and offal
        6
        day
    • Cat
    • Horse
      • Meat and offal
        8
        day
      • Milk
        no withdrawal period
    • Goat
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Dog
  • Intraarticular use
    • Horse
      • Meat and offal
        8
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02AB02
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
  • Alfasan Nederland B.V.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 84804/21-09-2021/K-0246601
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0430/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden

Documents

Combined File of all Documents

English (PDF)
Published on: 16/12/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."